FDA Commissioner Makary resigns

Dr. Marty Makary has resigned as Commissioner of the Food and Drug Administration after a 13-month tenure defined by frequent policy disputes with the Trump administration.

His departure was reportedly triggered by a final disagreement over the approval of flavored e-cigarettes, a move Makary opposed on public health grounds.

President Trump has appointed Kyle Diamantas, a former corporate lawyer, to serve as acting commissioner.

Makary's resignation leaves a significant leadership void at the Department of Health and Human Services as the nation grapples with ongoing public health challenges and regulatory overhauls.